The U.S. pharmaceutical market is the world’s most important national market. The United States alone holds over 45 percent of the global pharmaceutical market. In 2016, this share was valued around 446 billion U.S. dollars. Many of the global top companies are from the United States. In 2016, six out of the top 10 companies were from the United States when based on pure pharmaceutical revenue.
“Generic medicines will continue to provide the vast majority of the prescription drug usage in the United States, rising from 88% to 91% to 92% of all prescriptions dispensed by 2020,” stated IMS Institute’s Global Medicines Use in 2020: Outlook and Implications report.
Notably, generics that entered the market between 2002 and 2014 reduced the price of medications by 51% in the first year and 57% in the second year following loss of exclusivity, stated IMS Institute. “Prices of oral medicines were reduced further, by 66% in the first year and 74% in the second year after generic entry,” IMS Institute said in another report.
In order to serve the ever increasing demands of generics in the US Market, we are working hard to get the fastest moving products from authorized manufacturers at the most affordable prices possible. Our priority has always been to help the independent and small/ medium group of pharmacies, family owned and neighbourhood pharmacies to make the most savings on drugs purchases. With the reimbursement on generics going down with every quarter we are here to help you save as much as you can on purchasing and at the same time providing help and guidance with the NDCs that pay better reimbursement statewise.